Mallinckrodt plc (NYSE: MNK) today announced that the US Food and Drug Administration (FDA) has approved Xartemis XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets (CII), previously known as MNK-795, for the management of acute pain . ... ...

64 people liked this